← Open Payments lookup

DANIEL SIMON: Open Payments

NPI 1639471667 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$614 in 25 payments from 9 companies in 2025. Trend: 2023 $369 · 2024 $382 · 2025 $614

Food & beverage: $563Education: $51
CompanyPaymentsAmount
ABBVIE INC.10$195
Janssen Biotech, Inc.4$142
Madrigal Pharmaceuticals2$69
Takeda Pharmaceuticals U.S.A., Inc.3$67
Aimmune Therapeutics, Inc.2$45
Pharmacosmos Therapeutics Inc.1$39
Regeneron Healthcare Solutions, Inc.1$24
Gilead Sciences, Inc.1$19
Novo Nordisk Inc1$14

Products named: TREMFYA, MAVYRET, REZDIFFRA, ENTYVIO, ZENPEP, MONOFERRIC, CREON, VIBERZI.

Industry payments across WA — which companies pay providers there.